Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001193125-21-266597
Filing Date
2021-09-07
Accepted
2021-09-07 16:06:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3/A d159178df3a.htm F-3/A 596271
2 EX-5.1 d159178dex51.htm EX-5.1 78766
3 EX-23.1 d159178dex231.htm EX-23.1 1700
4 GRAPHIC g159178g05a44.jpg GRAPHIC 45879
5 GRAPHIC g159178g32e42.jpg GRAPHIC 46442
6 GRAPHIC g159178g77x26.jpg GRAPHIC 46442
7 GRAPHIC g159178page1.jpg GRAPHIC 4834
  Complete submission text file 0001193125-21-266597.txt   876094
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-258495 | Film No.: 211239368
SIC: 2834 Pharmaceutical Preparations